Tchaikapharma

Über Tchaikapharma

Die Beschreibung des Unternehmens ist auf Englisch.

CL BioPharma is the largest and fastest growing vertically integrated healthcare powerhouse on the Balkans. The group’s superior business model spans over the entire medicine life cycle, including:

1. late stages clinical trials management, proof-of-concept and safety profile studies

2. market research with unmatched accuracy and outsourced R&D (dossier development)

3. state-of the-art pharmaceutical cGMP-compliant manufacturing

4. scientific marketing & promotion and pharmaceuticals launches

5. wholesale & distribution

6. retail pharmacies management, and much more

The group flagship and manufacturing arm Tchaikapharma is the growth driver and profitability lynchpin keeping sharp eye on both in-licensing rights from the majors and introducing branded generics. Local production for 12 originals in CVS, CNS, diabetes, respiratory disease and 16 generics presently on the market will be followed by 33 new marketing authorizations in 2006 allowing for clinical coverage and tailor-made therapeutic baskets in all chief diagnoses. Every new product to become a leader in its respective therapeutic class within the first year after registration is already an established rule.